AKT2 and systemic sclerosis: In summary, this study selected eleven autoantibodies in the plasma of SSc patients, eight of which target proteins linked to fibrosis (PIP4K2B, VEGFB, AKT2, AKT3, SMAD2, SERPINB13, IL31, and CTGF), with some part of the TGF-beta pathway.